These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12499278)

  • 1. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.
    Sabino MA; Ghilardi JR; Jongen JL; Keyser CP; Luger NM; Mach DB; Peters CM; Rogers SD; Schwei MJ; de Felipe C; Mantyh PW
    Cancer Res; 2002 Dec; 62(24):7343-9. PubMed ID: 12499278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin diminishes advanced bone cancer pain.
    Luger NM; Honore P; Sabino MA; Schwei MJ; Rogers SD; Mach DB; Clohisy DR; Mantyh PW
    Cancer Res; 2001 May; 61(10):4038-47. PubMed ID: 11358823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin and the tumorigenic component of bone cancer pain.
    Peters CM; Lindsay TH; Pomonis JD; Luger NM; Ghilardi JR; Sevcik MA; Mantyh PW
    Neuroscience; 2004; 126(4):1043-52. PubMed ID: 15207337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis.
    Sevcik MA; Luger NM; Mach DB; Sabino MA; Peters CM; Ghilardi JR; Schwei MJ; Röhrich H; De Felipe C; Kuskowski MA; Mantyh PW
    Pain; 2004 Sep; 111(1-2):169-80. PubMed ID: 15327821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
    Kundu N; Fulton AM
    Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.
    Peters CM; Ghilardi JR; Keyser CP; Kubota K; Lindsay TH; Luger NM; Mach DB; Schwei MJ; Sevcik MA; Mantyh PW
    Exp Neurol; 2005 May; 193(1):85-100. PubMed ID: 15817267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.
    Gamradt SC; Feeley BT; Liu NQ; Roostaeian J; Lin YQ; Zhu LX; Sharma S; Dubinett SM; Lieberman JR
    Anticancer Res; 2005; 25(1A):107-15. PubMed ID: 15816526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
    Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
    Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.
    Honore P; Luger NM; Sabino MA; Schwei MJ; Rogers SD; Mach DB; O'keefe PF; Ramnaraine ML; Clohisy DR; Mantyh PW
    Nat Med; 2000 May; 6(5):521-8. PubMed ID: 10802707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism-based understanding of bone cancer pain.
    Mantyh PW
    Novartis Found Symp; 2004; 261():194-214; discussion 214-9, 256-61. PubMed ID: 15469052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the spinal NMDA receptor/PKCγ signaling pathway in the development of bone cancer pain.
    Xiaoping G; Xiaofang Z; Yaguo Z; Juan Z; Junhua W; Zhengliang M
    Brain Res; 2010 Jun; 1335():83-90. PubMed ID: 20362561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms that generate and maintain bone cancer pain.
    Mantyh PW; Hunt SP
    Novartis Found Symp; 2004; 260():221-38; discussion 238-40, 277-9. PubMed ID: 15283453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
    Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
    Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
    Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
    Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II.
    Katagiri M; Ogasawara T; Hoshi K; Chikazu D; Kimoto A; Noguchi M; Sasamata M; Harada S; Akama H; Tazaki H; Chung UI; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2006 Feb; 21(2):219-27. PubMed ID: 16418777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.
    Furuse S; Kawamata T; Yamamoto J; Niiyama Y; Omote K; Watanabe M; Namiki A
    Anesthesiology; 2009 Jul; 111(1):173-86. PubMed ID: 19512863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.